Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Biotechnology  >  General Biotech

ExonHit Therapeutics SA Product Pipeline Analysis


Published Date: August 2008
Published By: Global Markets Direct
Page Count: 27
Order Code: R3480-5730
 
DescriptionTable of ContentsSimilar
Products

ExonHit Therapeutics SA Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a ExonHit Therapeutics SA’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope
  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.
Reasons to buy
  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.
  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.
  • Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Similar Products
Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
Published Dec 2008 by Kalorama Information


Biotechnology Report
Published Nov 2008 by Wall Street Transcript


MarketWatch: Biotechnology
Published Nov 2008 by Datamonitor


Amgen Inc. - SWOT Analysis - SWOT Analysis
Published Nov 2008 by Datamonitor


13th Annual International Detection Technologies 2008 Conference Documentation
Published Nov 2008 by Knowledge Foundation


Biodetection Technologies 5th Edition
Published Nov 2008 by Knowledge Foundation


The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
Published Nov 2008 by PharmaVentures Ltd.


Freedonia Focus on Biochip Products & Services
Published Nov 2008 by Freedonia Focus


Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
Published Nov 2008 by Kalorama Information


Biotechnology in the US - Industry Risk Rating Report
Published Oct 2008 by IBISWorld




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com